Literature DB >> 17542464

CDC and progress toward integration of HIV, STD, and viral hepatitis prevention.

John W Ward1, Kevin A Fenton.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17542464      PMCID： PMC1831806          DOI： 10.1177/00333549071220S220

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  11 in total

1.  Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.

Authors:  Peter Whiticar; Thomas Liberti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Estimating the sensitivity and specificity of matching name-based with non-name-based case registries.

Authors:  P Etkind; Y Tang; M Whelan; S Ratelle; J Murphy; S Sharnprapai; A Demaria
Journal:  Epidemiol Infect       Date:  2003-08       Impact factor: 2.451

Review 3.  Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.

Authors:  J N Wasserheit
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

4.  1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-01-23

5.  Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project.

Authors:  Robert A Gunn; Paula J Murray; Carolyn H Brennan; David B Callahan; Miriam J Alter; Harold S Margolis
Journal:  Sex Transm Dis       Date:  2003-04       Impact factor: 2.830

6.  Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services.

Authors:  R A Gunn; P J Murray; M L Ackers; W G Hardison; H S Margolis
Journal:  Sex Transm Dis       Date:  2001-03       Impact factor: 2.830

7.  Establishing a viral hepatitis prevention and control program: Florida's experience.

Authors:  Linda M Baldy; Cheryl Urbas; Jennie L Harris; T Stephen Jones; Philip E Reichert
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

8.  Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado.

Authors:  Julie Subiadur; Jennie L Harris; Cornelis A Rietmeijer
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

9.  Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005.

Authors:  Richard Zimmerman; Carol Finley; Charlie Rabins; Karen McMahon
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

10.  Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care?

Authors:  Robin R Hennessy; Isaac B Weisfuse; Karen Schlanger
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792
View more
  6 in total

1.  Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.

Authors:  Peter Whiticar; Thomas Liberti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Program collaboration and service integration activities among HIV programs in 59 U.S. health departments.

Authors:  Lauren F Fitz Harris; Lauren Toledo; Erica Dunbar; Gustavo A Aquino; Steven R Nesheim
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

4.  Bundling of STDs and HIV in Prevention Messages.

Authors:  Jon Poehlman; Jennifer D Uhrig; Allison Friedman; Monica Scales; Ann Forsythe; Susan J Robinson
Journal:  J Soc Mark       Date:  2015

5.  How often are major blood-borne pathogens found in eye patients? A serosurvey at an eye hospital in Southern China.

Authors:  Fang Duan; Qiang Huang; Jingyu Liao; Dajun Pang; Xiaofeng Lin; Kaili Wu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

6.  On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.

Authors:  Jemima A Frimpong; Thomas D'Aunno; David C Perlman; Shiela M Strauss; Alissa Mallow; Diana Hernandez; Bruce R Schackman; Daniel J Feaster; Lisa R Metsch
Journal:  Trials       Date:  2016-03-03       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.